Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Accounts Payables: 2022-2025

Historic Accounts Payables for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to $1.1 million.

  • Gossamer Bio's Accounts Payables fell 63.49% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 63.49%. This contributed to the annual value of $2.3 million for FY2024, which is 58.03% down from last year.
  • As of Q3 2025, Gossamer Bio's Accounts Payables stood at $1.1 million, which was down 40.51% from $1.9 million recorded in Q2 2025.
  • Gossamer Bio's 5-year Accounts Payables high stood at $5.5 million for Q4 2023, and its period low was $363,000 during Q3 2022.
  • Moreover, its 3-year median value for Accounts Payables was $2.3 million (2024), whereas its average is $2.5 million.
  • Its Accounts Payables has fluctuated over the past 5 years, first soared by 361.32% in 2023, then slumped by 63.49% in 2025.
  • Gossamer Bio's Accounts Payables (Quarterly) stood at $1.5 million in 2022, then spiked by 278.75% to $5.5 million in 2023, then crashed by 58.03% to $2.3 million in 2024, then crashed by 63.49% to $1.1 million in 2025.
  • Its last three reported values are $1.1 million in Q3 2025, $1.9 million for Q2 2025, and $3.4 million during Q1 2025.